Annual CFF
$19.59 M
+$13.38 M+215.82%
June 1, 2024
Summary
- As of March 6, 2025, RADX annual cash flow from financing activities is $19.59 million, with the most recent change of +$13.38 million (+215.82%) on June 1, 2024.
- During the last 3 years, RADX annual CFF has fallen by -$27.63 million (-58.51%).
- RADX annual CFF is now -58.51% below its all-time high of $47.21 million, reached on June 1, 2022.
Performance
RADX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RADX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +215.8% | - | - |
| 3 y3 years | -58.5% | - | - |
| 5 y5 years | -58.5% | - | - |
RADX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.5% | +215.8% | ||||
| 5 y | 5-year | -58.5% | +215.8% | ||||
| alltime | all time | -58.5% | +215.8% |
Radiopharm Theranostics Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | $19.59 M(+215.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | $6.20 M(-86.9%) | - | - |
| Jun 2022 | $47.21 M | - | - |
FAQ
- What is Radiopharm Theranostics Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual CFF year-on-year change?
What is Radiopharm Theranostics Limited annual cash flow from financing activities?
The current annual CFF of RADX is $19.59 M
What is the all time high annual CFF for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual cash flow from financing activities is $47.21 M
What is Radiopharm Theranostics Limited annual CFF year-on-year change?
Over the past year, RADX annual cash flow from financing activities has changed by +$13.38 M (+215.82%)